Jacek Zdybski

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 419 citations · Full text

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 242 citations · Full text

Asthma, Uncontrolled Atopic Dermatitis, Atopic Dermatitis +4

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Andrew Blauvelt, Jonathan I. Silverberg, Charles Lynde et al. · Journal of the American Academy of Dermatology · 2021 · 140 citations · Full text

Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial

Mauro Picardo, Carla Cardinali, M. La Plaça et al. · British Journal of Dermatology · 2022 · 24 citations · Full text

Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Amy S. Paller, Andreas Pinter, Lara Wine Lee et al. · Advances in Therapy · 2024 · 16 citations · Full text